EC committees lock horns on risk assessments for medicines

Moves to establish the first environmental risk assessment requirements for pharmaceuticals have prompted a disagreement between two EC expert committees. Proposals drawn up by the European medicines agency have been criticised by the Scientific Committee on Toxicity, Ecotoxicity and the Environment (CSTEE) for paying little attention to chronic toxicity risks to aquatic organisms and disregarding established approaches to risk assessment and toxicity testing.

Sorry you do not have access to this article. Please contact Customer Support at
or call 020 8267 8120